Comparison of the Efficacies of Topical Liposomal Amphotericin B and Topical Clotrimazole in the Treatment of Pityriasis Versicolor.

"Competing Interests: None."

"Funding: This work was supported by the Research Council of Shiraz University of Medical Sciences under Grant 22355."

"This study was conducted as a single-blind clinical trial from March 7 to July 22, 2022. The trial utilized systematic random sampling, and the blinding method is described in detail below. Ethical approval for the study was obtained from the Ethics Committee of Shiraz University of Medical Sciences in February 2021 (Ethical Committee Approval ID: IR.SUMS.MED.REC. 1399.543). The study was registered in the Iranian Registry of Clinical Trials on March 7, 2022, with trial registration number IRCT20220221054082N1. Written informed consent was obtained from all participants after explaining the study purpose, research procedures, and the protection of patients privacy. The publication of skin images included in the manuscript was done only with the patients’ written informed consent. The study adhered to the applicable CONSORT guidelines and was conducted in accordance with the principles stated in the Declaration of Helsinki."